We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

204 hedge funds and large institutions have $7.27B invested in BeOne Medicines Ltd in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 90 increasing their positions, 45 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 45

43% more funds holding in top 10

Funds holding in top 10: 7 → 10 (+3)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

8% more call options, than puts

Call options by funds: $14.2M | Put options by funds: $13.2M

0% more funds holding

Funds holding: 203 → 204 (+1)

0.11% more ownership

Funds ownership: 3.61% → 3.72% (+0.11%)

11% less capital invested

Capital invested by funds: $8.14B → $7.27B (-$872M)

Holders
204
Holders Change
+1
Holders Change %
+0.49%
% of All Funds
2.94%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.14%
New
38
Increased
90
Reduced
45
Closed
35
Calls
$14.2M
Puts
$13.2M
Net Calls
+$1.03M
Net Calls Change
+$365K

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$117M
2
VPC
Vestal Point Capital
New York
+$52.3M
3
Bank of America
Bank of America
North Carolina
+$28.5M
4
SCM
Soleus Capital Management
Connecticut
+$23.8M
5
Artisan Partners
Artisan Partners
Wisconsin
+$23.3M

Top Sellers

1
Invesco
Invesco
Georgia
-$43.4M
2
Morgan Stanley
Morgan Stanley
New York
-$32.1M
3
Goldman Sachs
Goldman Sachs
New York
-$25.1M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$22.2M
5
AI
Axiom Investors
Connecticut
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
101
New York State Common Retirement Fund
New York
$926K +$953K +5,921 New
BFG
102
Bleakley Financial Group
New Jersey
$885K +$313K +1,942 +52%
SW
103
Simplicity Wealth
New Jersey
$885K +$911K +5,657 New
Bank of New York Mellon
104
Bank of New York Mellon
New York
$844K +$351K +2,177 +68%
YIH
105
Y-Intercept (HK)
Hong Kong
$829K +$853K +5,299 New
Dimensional Fund Advisors
106
Dimensional Fund Advisors
Texas
$822K -$972K -6,036 -53%
Balyasny Asset Management
107
Balyasny Asset Management
Illinois
$801K +$824K +5,120 New
Deutsche Bank
108
Deutsche Bank
Germany
$773K -$1.61M -9,975 -67%
OCBCO
109
Oversea-Chinese Banking Corp (OCBC)
Singapore
$761K -$409K -2,537 -34%
Millennium Management
110
Millennium Management
New York
$738K -$419K -2,604 -36%
ECU
111
Eisler Capital (US)
New York
$722K +$743K +4,617 New
CGH
112
Crossmark Global Holdings
Texas
$680K +$43.6K +271 +7%
SAM
113
Sectoral Asset Management
Quebec, Canada
$577K -$9.66K -60 -2%
RB
114
Rodgers Brothers
Pennsylvania
$555K +$4.03K +25 +0.7%
Simplex Trading
115
Simplex Trading
Illinois
$537K +$554K +3,439 New
NW
116
NewEdge Wealth
Pennsylvania
$500K +$238K +1,475 +92%
VAS
117
Vestmark Advisory Solutions
Massachusetts
$483K +$240K +1,488 +93%
ProShare Advisors
118
ProShare Advisors
Maryland
$454K +$34.9K +217 +8%
CS
119
Credit Suisse
Switzerland
$453K +$198K +1,227 +74%
VWM
120
Venturi Wealth Management
Texas
$445K +$213K +1,324 +87%
HC
121
Henshaw Capital
Massachusetts
$434K +$217K +1,350 +95%
SMH
122
Sanders Morris Harris
Texas
$422K – – –
Fiera Capital (Canada)
123
Fiera Capital (Canada)
Quebec, Canada
$400K -$937K -5,820 -69%
Qube Research & Technologies (QRT)
124
Qube Research & Technologies (QRT)
United Kingdom
$396K -$300K -1,866 -42%
Ameriprise
125
Ameriprise
Minnesota
$394K -$362K -2,246 -47%
3 4
5
6 7

ONC Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2024, worth a combined $7.27B — down 11% from $8.14B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ONC positions and 35 closed out — a net gain of 3 holders — while 90 added to existing stakes and 45 trimmed.

The largest buyer was Capital International Investors, adding an estimated $117M. The largest seller was Invesco, cutting an estimated $43.4M.

  • 204 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2024, up from 203 in Q4 2023.
  • Funds reported $7.27B of BeOne Medicines Ltd stock for Q1 2024, down 11% quarter-over-quarter.
  • 38 funds opened new BeOne Medicines Ltd positions in Q1 2024 and 35 closed out, a net change of +3 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2024 was Capital International Investors, an estimated $117M added.
  • The largest BeOne Medicines Ltd seller in Q1 2024 was Invesco, an estimated $43.4M sold.

Based on aggregated 13F filings for Q1 2024.